Predictors of low-density lipoprotein particle size in a high-risk African-American population

被引:9
作者
Benton, JL
Blumenthal, RS
Becker, DM
Yanek, LR
Moy, TF
Post, W
机构
[1] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Div Internal Med, Baltimore, MD USA
关键词
D O I
10.1016/j.amjcard.2005.01.075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A predominance of small, dense, low-density lipoprotein particles (pattern B) has been associated with increased cardiovascular risk independent of absolute cholesterol. levels in primarily white populations. Because of the putative association of pattern B with increased risk, some investigators have proposed that routine measurement of low-density lipoprotein particle size may be beneficial for cardiovascular risk assessment. Because no studies have specifically examined this possibility in African-Americans, it remains unclear whether measurement of low-density lipoprotein particle size adds information beyond that of traditional lipid risk factors. We compared standard lipid profile measurements with extended measurements concurrently in an apparently healthy, high-risk population of African-American siblings of patients who had premature cardiovascular disease. We determined the extent to which patients who had pattern B would be identifiable from the usual. lipid profile. A high triglyceride level alone was a strong independent correlate of pattern B. In subjects whose triglycericle level was >= 150 mg/dl, 67% had pattern B, whereas only 17% of subjects whose triglycericle level was < 150 mg/dl had pattern B. The area under the receiver-operating characteristic curve was 0.77. Our data suggest that the standard lipid profile, primarily fasting triglycericle measurement, appears to be a useful surrogate for direct measurement of particle size in a high-risk African-American population. (c) 2005 by Excerpta Medica Inc.
引用
收藏
页码:1320 / 1323
页数:4
相关论文
共 28 条
[1]   Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease - Application of the second Adult Treatment Panel guidelines [J].
Allen, JK ;
Young, DR ;
Blumenthal, RS ;
Moy, TF ;
Yanek, LR ;
Wilder, L ;
Becker, LC ;
Becker, DM .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (15) :1654-1660
[2]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[3]   Lipoprotein distribution in the metabolic syndrome, type 2 diabetes mellitus, and familial combined hyperlipidemia [J].
Ayyobi, AF ;
Brunzell, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (4A) :27J-33J
[4]   Markedly high prevalence of coronary risk factors in apparently healthy African-American and white siblings of persons with premature coronary heart disease [J].
Becker, DM ;
Yook, RM ;
Moy, TF ;
Blumenthal, RS ;
Becker, LC .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (09) :1046-1051
[5]   Metabolic origins and clinical significance of LDL heterogeneity [J].
Berneis, KK ;
Krauss, RM .
JOURNAL OF LIPID RESEARCH, 2002, 43 (09) :1363-1379
[6]   Exercise thallium tomography predicts future clinically manifest coronary heart disease in a high-risk asymptomatic population [J].
Blumenthal, RS ;
Becker, DM ;
Moy, TF ;
Coresh, J ;
Wilder, LB ;
Becker, LC .
CIRCULATION, 1996, 93 (05) :915-923
[7]  
Brunzell JD, 1999, DIABETES CARE, V22, pC10
[8]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[9]  
Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499